Xi Yan

1.4k total citations
65 papers, 1.1k citations indexed

About

Xi Yan is a scholar working on Molecular Biology, Plant Science and Pharmacology. According to data from OpenAlex, Xi Yan has authored 65 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 25 papers in Plant Science and 13 papers in Pharmacology. Recurrent topics in Xi Yan's work include Natural product bioactivities and synthesis (19 papers), Phytochemistry and Biological Activities (14 papers) and Natural Compound Pharmacology Studies (9 papers). Xi Yan is often cited by papers focused on Natural product bioactivities and synthesis (19 papers), Phytochemistry and Biological Activities (14 papers) and Natural Compound Pharmacology Studies (9 papers). Xi Yan collaborates with scholars based in South Korea, China and Japan. Xi Yan's co-authors include Young Ho Kim, Seo Young Yang, Wei Li, Ya Nan Sun, Hae‐Dong Jang, Sanghyun Lee, Jin‐Ming Gao, Hee Kyoung Kang, Yan Ding and Young‐Sang Koh and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Food Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Xi Yan

62 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xi Yan 475 336 198 158 130 65 1.1k
Chia‐Ying Li 662 1.4× 428 1.3× 291 1.5× 211 1.3× 152 1.2× 68 1.4k
Najihah Mohd Hashim 642 1.4× 450 1.3× 189 1.0× 126 0.8× 244 1.9× 88 1.5k
Yuqing Jian 653 1.4× 391 1.2× 166 0.8× 214 1.4× 84 0.6× 64 1.3k
Raj Kumar 425 0.9× 190 0.6× 212 1.1× 105 0.7× 134 1.0× 51 1.1k
Hamed Karimian 533 1.1× 234 0.7× 121 0.6× 120 0.8× 209 1.6× 42 1.5k
Suvitha Syam 385 0.8× 267 0.8× 146 0.7× 171 1.1× 268 2.1× 18 999
Dajian Yang 578 1.2× 366 1.1× 208 1.1× 125 0.8× 107 0.8× 53 1.2k
Manasi Deshpande 437 0.9× 164 0.5× 137 0.7× 129 0.8× 83 0.6× 17 975
Zhifeng Li 608 1.3× 225 0.7× 192 1.0× 88 0.6× 97 0.7× 69 1.0k

Countries citing papers authored by Xi Yan

Since Specialization
Citations

This map shows the geographic impact of Xi Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Yan more than expected).

Fields of papers citing papers by Xi Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Yan. The network helps show where Xi Yan may publish in the future.

Co-authorship network of co-authors of Xi Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Yan. A scholar is included among the top collaborators of Xi Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Yan. Xi Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Yan, Lu Zhang, Chunmei Liu, et al.. (2025). Exploring palliative care needs of advanced AIDS patients in China: insights from a descriptive phenomenological study. BMC Palliative Care. 24(1). 42–42.
2.
Zhang, Qiongwen, et al.. (2024). Case report: outcome of anlotinib treatment in breast cancer patient with brain metastases. Frontiers in Pharmacology. 15. 1381478–1381478.
4.
Zhang, Qiongwen, Ping He, Xi Yan, et al.. (2023). Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study. Frontiers in Pharmacology. 14. 1100556–1100556. 8 indexed citations
5.
Zhong, Xiaorong, Ping He, Jie Chen, et al.. (2022). Neoadjuvant pyrotinib plus trastuzumab and nab-paclitaxel for HER2-positive early or locally advanced breast cancer: an exploratory phase II trial. Gland Surgery. 11(1). 216–225. 14 indexed citations
6.
Xu, Shengchao, Xi Yan, Gan Dai, & Chengke Luo. (2021). A Novel Mice Model for Studying the Efficacy and IRAEs of Anti-CTLA4 Targeted Immunotherapy. Frontiers in Oncology. 11. 692403–692403. 4 indexed citations
7.
Kou, Rong-Wei, Xi Yan, Qıang Zhang, et al.. (2018). Cyathane diterpenoids and drimane sesquiterpenoids with neurotrophic activity from cultures of the fungus Cyathus africanus. The Journal of Antibiotics. 72(1). 15–21. 29 indexed citations
9.
Sun, Ya Nan, Wei Li, Seok Bean Song, et al.. (2015). NF-κB Inhibitory Activities of Phenolic and Lignan Components from the Stems of Acanthopanax divaricatus var. albeofructus. Natural Product Sciences. 20(4). 232–236. 3 indexed citations
10.
Sun, Ya Nan, Jang Hoon Kim, Wei Li, et al.. (2015). Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe. Bioorganic & Medicinal Chemistry. 23(20). 6659–6665. 17 indexed citations
11.
Yan, Xi, Yan Ding, Sang Hyun Lee, et al.. (2014). Evaluation of the Antioxidant Activities of Natural Components of Artemisia iwayomogi. Natural Product Sciences. 20(3). 176–181. 2 indexed citations
12.
Yan, Xi, Sanghyun Lee, Wei Li, et al.. (2014). Evaluation of the antioxidant and anti-osteoporosis activities of chemical constituents of the fruits of Prunus mume. Food Chemistry. 156. 408–415. 69 indexed citations
13.
Sun, Ya Nan, Wei Li, Jang Hoon Kim, et al.. (2014). Chemical constituents from the root of Polygonum multiflorum and their soluble epoxide hydrolase inhibitory activity. Archives of Pharmacal Research. 38(6). 998–1004. 17 indexed citations
14.
Yan, Xi, Sanghyun Lee, Wei Li, Hae‐Dong Jang, & Young Ho Kim. (2014). Terpenes and sterols from the fruits of Prunus mume and their inhibitory effects on osteoclast differentiation by suppressing tartrate-resistant acid phosphatase activity. Archives of Pharmacal Research. 38(2). 186–192. 37 indexed citations
15.
Yan, Xi, Wei Li, Yanan Sun, et al.. (2014). Identification and biological evaluation of flavonoids from the fruits of Prunus mume. Bioorganic & Medicinal Chemistry Letters. 24(5). 1397–1402. 30 indexed citations
16.
Li, Wei, Yan Ding, Ya Nan Sun, et al.. (2013). Oleanane-type triterpenoid saponins from the roots of Pulsatilla koreana and their apoptosis-inducing effects on HL-60 human promyelocytic leukemia cells. Archives of Pharmacal Research. 36(6). 768–774. 19 indexed citations
17.
Li, Wei, Ya Nan Sun, Xi Yan, et al.. (2012). Chemical Constituents from the Bark of Phellodendron amurense and Their Cytotoxic Effects on HL-60 Human Leukemia Cells. Natural Product Sciences. 18(4). 250–253. 2 indexed citations
18.
Chen, Jianbo, Xi Yan, Young Ho Kim, et al.. (2011). Comparative pharmacokinetics of three marker compounds in mBHT and single-herb extract after oral administration to rats. Journal of Pharmaceutical and Biomedical Analysis. 56(5). 1121–1126. 6 indexed citations
20.
Yan, Xi. (2005). Influence of cerebrovascular endothelial cell lesion on the neuronal apoptosis during cerebral ischemia-reperfusion of rats. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026